|
Volumn 49, Issue 16, 2007, Pages 1676-1683
|
Polymer-Based, Paclitaxel-Eluting TAXUS Liberté Stent in De Novo Lesions. The Pivotal TAXUS ATLAS Trial
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTITHROMBIN;
CLOPIDOGREL;
FIBRINOGEN RECEPTOR ANTAGONIST;
HEPARIN;
PACLITAXEL;
TICLOPIDINE;
ADULT;
AGED;
ANGIOCARDIOGRAPHY;
ARTERY DIAMETER;
ARTICLE;
CLINICAL TRIAL;
CONFIDENCE INTERVAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG ELUTING STENT;
FEMALE;
HEART INFARCTION;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
PERCUTANEOUS CORONARY INTERVENTION;
PRIORITY JOURNAL;
QUANTITATIVE ANALYSIS;
REVASCULARIZATION;
AGED;
CORONARY STENOSIS;
ENDPOINT DETERMINATION;
EQUIPMENT DESIGN;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
NEOVASCULARIZATION, PHYSIOLOGIC;
PACLITAXEL;
POLYMERS;
PROSPECTIVE STUDIES;
STENTS;
TUBULIN MODULATORS;
|
EID: 34247151092
PISSN: 07351097
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jacc.2007.01.069 Document Type: Article |
Times cited : (108)
|
References (5)
|